Gene Query: MCM9

Dataset Description Geneva Score
MARS Seq data from human cortical organoids 21.97
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 11.38
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 11.38
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 9.98
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 8.68
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 7.77
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 7.75
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 7.38
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 7.28
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 7.28
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 6.37
Global expression profiles in cardiac progenitor cells generated by ISX-9 6.37
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 5.86
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.27
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 4.54
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 4.51
Transcriptional landscape changes during human embryonic stem cell derivation 4.41
Landscape of H3K4me3 in human CD19 cells 4.37
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 4.3
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.15
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.15
Targeting MTHFD2 in Acute Myeloid Leukemia 4.09
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 4.05
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 4.02
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 3.99
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 3.91
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.89
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 3.82
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 3.79
Human cell line and subcutaneous tumor 3.78
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.74
DRB/GRO-Seq -/+ UV 3.66
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 3.65
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 3.63
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 3.5
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 3.43
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 3.31
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 3.3
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.28
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.27
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.22
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 3.21
Effect of PRDM11 depletion in U2932 cells 3.08
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 3.07
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.07
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.07
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 3.0
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.99
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.91
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.82
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.76
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.74
Transcriptome analysis of CNS leukemia 2.74
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 2.74
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 2.69
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 2.67
The effect of Abl kinases on non-small cell carcinoma global transcriptome 2.65
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.6
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.6
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 2.59
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 2.59
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 2.57
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 2.56
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 2.53
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 2.48
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 2.42
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.42
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.39
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.38
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.36
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.36
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.35
Global Mapping of Human RNA-RNA Interactions 2.32
Gene expression analysis of the impact of TDP-43 knockout in human cells. 2.3
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 2.28
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.28
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 2.26
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 2.23
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.23
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.23
Short and Long RNA sequencing of human mature erythrocytes 2.22
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.21
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.2
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 2.19
LncRNA expression profiling of ischemic stroke patients 2.19
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.18
Characterization of human ILC2 subsets 2.15
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.13
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.13
Gene expression in PANC1 cells treated with Rakicidin 2.12
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.12
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.12
NRDE2 negatively regulates nuclear exosome functions 2.1
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 2.09
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.08
4sUDRB-seq: measuring transcription elongation and initiation genomewide 2.08
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.07
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.05
MicroRNA-125a-5p overexpression in human macrophages 2.03
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.99
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 1.98
HNRNPL and its RNA Targets in Prostate Cancer 1.97
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 1.97
Impact of dieldrin on transcription in Jurkat T cells 1.96
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 1.96
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 1.95
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 1.94
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 1.92
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.92
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.91
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.91
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.9
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.9
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 1.9
U1 snRNP telescripting regulates size-function stratified human genome 1.89
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.88
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 1.86
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.85
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 1.84
Zika infected neural stem cells 1.84
Transcriptome analysis of Zika infected neural stem cells 1.84
RNA-seq of YB5 cells treated with Proscillaridin A 1.83
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 1.82
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.82
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.81
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.8
Transcriptome Profiling of Human Primary Monocytes 1.8
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.8
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.77
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 1.75
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.73
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.73
ARID1A regulates condensin II distribution and chromosomal partition 1.72
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 1.72
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.72
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.71
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 1.71
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.7
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 1.68
Rorc disruption in human FG pancreatic cancer cells 1.68
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.67
LIN28A Over-expression RNAseq 1.67
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 1.67
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 1.67
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 1.67
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.66
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.65
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.65
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 1.65
Recovery and analysis of nascent RNA 1.65
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.65
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 1.64
MAIT cell RNA sequencing 1.64
Systematic discovery of endogenous human ribonucleoprotein complexes 1.63
TGF-β regulation of miRNA expression in pancreatic cancer 1.63
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.63
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 1.63
Determining mRNA half-lives on a transcriptome-wide scale 1.63
Seletive inhibition of CDK9 in DLBCL cell lines 1.61
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 1.61
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 1.6
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 1.6
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.6
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 1.6
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.59
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 1.59
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 1.58
circRNA-sequencing 1.58
Hijacking of stress response machinery by oncogenes in acute leukaemia 1.58
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 1.58
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 1.58
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.57
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.57
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 1.54
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 1.54
R430: A potent inbibitor of DNA and RNA viruses 1.54
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.53
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.53
RNA-seq in transgenic cells 1.53
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.53
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 1.51
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 1.5
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.49
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.48
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 1.48
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 1.47
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 1.47
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 1.47
Biological effect of chronic mistranslation in mammalian cells 1.47
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 1.43
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 1.43
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.42
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.41
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.41
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.41
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 1.4
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.39
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.39
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 1.39
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.38
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 1.36
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.36
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.35
HEK293 TFAM Knockout Expression Study 1.35
Gene expression in GBM with Cav3.2 inhibition 1.33
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.33
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 1.32
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 1.32
mRNA expression profile of Lymphocytes by high-throuput sequencing 1.32
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.31
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 1.31
Global analysis of alternative splicing regulated by RBM10 1.31
Transcriptional profile in human S. haematobium infection 1.31
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 1.31
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.3
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.3
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 1.3
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 1.29
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.29
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.28
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.27
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.26
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.26
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.26
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.25
Total RNA-seq in ALL-SIL upon JQ1 inhibition 1.23
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.23
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.23
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.23
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.22
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.22
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.22
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.21
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.21
The DPYSL2 gene connects mTOR and schizophrenia 1.2
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.2
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.19
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.19
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 1.18
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.17
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.17
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 1.17
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.16
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.15
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 1.15
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.15
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 1.14
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.14
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.14
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 1.13
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.12
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 1.12
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 1.12
Controlling for gene expression changes in transcription factor protein networks. 1.11
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 1.1
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.1
Modulation of nonsense-mediated decay by rapamycin 1.1
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.09
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.09
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.09
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.09
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.09
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.08
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 1.08
Accurate annotation of human protein-coding small open reading frames 1.08
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 1.07
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 1.07
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.06
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 1.05
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.04
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 1.04
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.04
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.04
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.03
Mapping interactions for the TNIP2 hub protein 1.03
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 1.02
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.01
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.01
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.0
Transcriptome analysis of BAP1 knockout and restoration 1.0
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 1.0
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.0
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 1.0
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 0.98
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 0.95
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.95
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.95
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.94
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.93
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.92
PTHrP overexpression in MCF7 cells 0.92
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 0.91
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.91
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 0.9
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.9
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.9
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.88
TT-Seq captures the human transient transcriptome 0.87
Ribosomal protein RPL26 is the principal target of UFMylation 0.86
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.84
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.84
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.84
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.84
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.84
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.83
RNA-seq of cancer cell lines treated with T-025 0.81
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.79
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.79
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.78
Total RNA-Seq data from leukemic patients with complex structural variants 0.78
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.78
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.78
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.76
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.76
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.76
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.76
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.76
RNA-seq analysis of differentiating human erythroblasts 0.72
Discovering human diabetes-risk gene function with genetics and physiological assays 0.71
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.71
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.71
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.71
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.71
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.71
The transcriptome effect of overexpressing EZH2 in MCF7 0.71
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 0.7
Global transcriptome analysis of WT versus HEB-/- hESCs 0.69
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.69
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 0.67
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.67
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 0.66
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 0.66
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.66
Intron retention induced by microsatellite expansions as a disease biomarker. 0.65
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.65
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 0.65
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.65
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.65
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.65
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 0.63
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.62
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 0.62
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.61
Determination of tRNA aminoacylation levels by high throughput sequencing 0.6
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.6
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.6
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.59
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.59
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.59
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.58
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.58
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.58
Functional significance of the HIV-1 Tat signature amino acid residues 0.57
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.56
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.55
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.54
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.54
Transcriptomic analysis of frontal fibrosing alopecia 0.53
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.53
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.53
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.52
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.52
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.52
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.5
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.49
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.48
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.48
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.47
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.46
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.45
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.45
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.45
Transcription elongation regulates genome 3D structure 0.44
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.43
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.43
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.42
The pause-initiation limit restricts transcription activation in human cells 0.42
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.41
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.41
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.41
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.41
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.41
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.4
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.39
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.38
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.38
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.38
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.38
RNA-seq of primary patient AML samples 0.38
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.37
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.37
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.37
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.36
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.36
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.35
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.35
CD74 role in transcription regulation [RNA-seq] 0.34
CD74 role in transcription regulation 0.34
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.33
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.33
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.33
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.32
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.32
Myc activation coordinates gene transcription and protein translation responses 0.32
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.31
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.31
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.31
RNA expression analysis upon JMJD1C depletion 0.31
Loss of CREBBP results in gene expression repression in lymphoma cells 0.3
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.3
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.28
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 0.27
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.26
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.25
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.24
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.24
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.24
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.24
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.23
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.23
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.23
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.23
ML29755 RNA-seq data 0.23
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.22
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.22
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.22
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.22
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.21
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.21
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 0.21
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.21
Interphase condensins regulate ligand-depedent enhancer activation 0.21
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.21
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.21
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.21
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.21
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.2
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 0.2
Function and hormonal regulation of GATA3 in human first trimester placentation 0.19
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.18
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.17
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.17
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.17
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.17
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.17
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.17
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.17
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.16
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.16
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.15
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.15
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 0.15
Human Tfh cell RNA bulk sequencing 0.14
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.13
Gene expression analysis of human hepatocellular cancers 0.13
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.13
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.12
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.12
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.12
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.12
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.12
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.11
RNA-seq data 0.11
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.11
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.11
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.11
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.1
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.1
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.08
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.08
Aging-associated patterns in the expression of human endogenous retroviruses 0.08
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.08
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.07
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.07
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.07
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.07
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.07
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 0.06
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 0.06
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 0.06
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.05
quanTIseq: quantifying immune contexture of human tumors 0.05
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.05
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.05
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.05
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.04
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.04
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.03
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.03
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.02
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.02
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.02
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 0.02
Stem and effector CD8 T-cells from human cancers 0.01
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.0
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation